158 related articles for article (PubMed ID: 12861974)
1. Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA.
Vere Hodge A
IDrugs; 2003 Jun; 6(6):515-7. PubMed ID: 12861974
[No Abstract] [Full Text] [Related]
2. Newer treatments for HIV in children.
McKinney RE; Cunningham CK
Curr Opin Pediatr; 2004 Feb; 16(1):76-9. PubMed ID: 14758118
[TBL] [Abstract][Full Text] [Related]
3. The importance of sequencing in treatment options.
Berger DS
Posit Aware; 2001; 12(3):42-3. PubMed ID: 11686121
[No Abstract] [Full Text] [Related]
4. The treatment pipeline: new therapies are on the way.
Boyle BA
AIDS Read; 1999 Nov; 9(8):519-20, 523-5, 528-9. PubMed ID: 11082727
[No Abstract] [Full Text] [Related]
5. Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Suboptimal response to once-daily abacavir + 3TC + tenofovir.
Feinberg J
AIDS Clin Care; 2003 Nov; 15(11):94. PubMed ID: 14682272
[No Abstract] [Full Text] [Related]
6. Tenofovir helps beat hepatitis B.
TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
[No Abstract] [Full Text] [Related]
7. Tenofovir, equivalence, and noninferiority.
Parienti JJ
JAMA; 2004 Oct; 292(16):1951; author reply 1951-2. PubMed ID: 15507576
[No Abstract] [Full Text] [Related]
8. Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection.
Polk C; Chan-Tack KM; Kopack AM; Amoroso A
AIDS Patient Care STDS; 2007 Feb; 21(2):75-7. PubMed ID: 17328655
[No Abstract] [Full Text] [Related]
9. Tenofovir ready for approval.
AIDS Patient Care STDS; 2001 Jul; 15(7):399. PubMed ID: 11483167
[No Abstract] [Full Text] [Related]
10. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
11. Drugs in development.
AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058698
[No Abstract] [Full Text] [Related]
12. Tenofovir gel studied.
AIDS Patient Care STDS; 2002 Aug; 16(8):401-2. PubMed ID: 12227991
[No Abstract] [Full Text] [Related]
13. Cambodia: can a drug provide some protection?
Cohen J
Science; 2003 Sep; 301(5640):1660-1. PubMed ID: 14500956
[No Abstract] [Full Text] [Related]
14. 8th European Conference on Clinical Aspects and Treatment of HIV Infection, Athens, 28-31 October 2001.
Palfreeman A; Huengsberg M
Sex Transm Infect; 2002 Apr; 78(2):149. PubMed ID: 12081181
[No Abstract] [Full Text] [Related]
15. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
16. Can AIDS drug also prevent HIV infection?
AIDS Read; 2004 Jan; 14(1):14. PubMed ID: 14959699
[No Abstract] [Full Text] [Related]
17. Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies.
Negredo E; Bonjoch A; Paredes R; Puig J; Clotet B
Clin Infect Dis; 2005 Sep; 41(6):901-5. PubMed ID: 16107993
[TBL] [Abstract][Full Text] [Related]
18. Prodrug of tenofovir diphosphate approved for combination HIV therapy.
Thompson CA
Am J Health Syst Pharm; 2002 Jan; 59(1):18. PubMed ID: 11813460
[No Abstract] [Full Text] [Related]
19. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Tenofovir or adefovir for hepatitis B.
TreatmentUpdate; 2006; 18(2):4. PubMed ID: 17228455
[No Abstract] [Full Text] [Related]
20. HIV and hepatitis B virus: options for managing coinfection.
Dieterich DT
Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
